Publikationen im NUM
Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.
M. Renn,
E. Bartok,
T. Zillinger,
G. Hartmann and
R. Behrendt,
"Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions",
Pharmacology & Therapeutics,
pp. 107931,
2021.
| DOI: | 10.1016/j.pharmthera.2021.107931 |
D. Gagiannis,
V. G. Umathum,
W. Bloch,
C. Rother,
M. Stahl,
H. M. Witte,
S. Djudjaj,
P. Boor and
K. Steinestel,
"Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2",
Am J Clin Pathol,
2021.
| DOI: | 10.1093/ajcp/aqab087 |
O. Nikolai,
C. Rohardt,
F. Tobian and
et al,
"Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter?",
Infect Dis,
vol. 53,
no. 12,
2021.
| DOI: | 10.1080/23744235.2021.1969426 |
| Datei: | https://doi.org/10.1080/23744235.2021.1969426 |
M. Popp,
M. Stegemann,
M. Riemer,
M. Metzendorf,
C. S. Romero,
A. Mikolajewska,
P. Kranke,
P. Meybohm,
N. Skoetz and
S. Weibel,
"Antibiotics for the treatment of COVID‐19",
Cochrane Database of Systematic Reviews,
vol. 2021,
pp. CD015025,
2021.
| DOI: | 10.1002/14651858.CD015025 |
K. Althaus,
I. Marini,
J. Zlamal,
L. Pelzl,
A. Singh,
H. Häberle,
M. Mehrländer,
S. Hammer,
H. Schulze,
M. Bitzer,
N. Malek,
D. Rath,
H. Bösmüller,
B. Nieswandt,
M. Gawaz,
T. Bakchoul and
P. Rosenberger,
"Antibody-induced procoagulant platelets in severe COVID-19 infection",
Blood,
vol. 137,
no. 8,
pp. 1061—1071,
Feb.
2021.
| DOI: | 10.1182/blood.2020008762 |
| Datei: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791311/ |
[en]
K. Althaus,
P. Möller,
G. Uzun,
A. Singh,
A. Beck,
M. Bettag,
H. Bösmüller,
M. Guthoff,
F. Dorn,
G. C. Petzold,
H. Henkes,
N. Heyne,
H. Jumaa,
K. Kreiser,
C. Limpach,
B. Luz,
M. Maschke,
J. A. Müller,
J. Münch,
S. Nagel,
B. Pötzsch,
J. Müller,
C. Schlegel,
A. Viardot,
H. Bäzner,
M. Wolf,
L. Pelzl,
V. Warm,
W. A. Willinek,
J. Steiner,
N. Schneiderhan-Marra,
D. Vollherbst,
U. J. Sachs,
F. Fend and
T. Bakchoul,
"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia",
Haematologica,
vol. 106,
no. 8,
pp. 2170—2179,
Mai
2021.
| DOI: | 10.3324/haematol.2021.279000 |
| Datei: | https://haematologica.org/article/view/haematol.2021.279000 |
P. Möller,
G. Uzun,
A. Singh,
A. Beck,
M. Bettag,
H. Bösmüller,
M. Guthoff,
F. Dorn,
G. C. Petzold,
H. Henkes,
N. Heyne,
H. Jumaa,
K. Kreiser,
C. Limpach,
B. Luz,
M. Maschke,
J. Müller,
J. Münch,
S. Nagel,
B. Pötzsch,
J. Müller,
C. Schlegel,
A. Viardot,
H. Bäzner,
M. Wolf,
L. Pelzl,
V. Warm,
W. A. Willinek,
J. Steiner,
N. Schneiderhan-Marra,
D. Vollherbst,
U. J. Sachs,
F. Fend and
T. Bakchoul,
"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia",
Haematologica,
vol. 106,
no. 8,
pp. 2170-2179,
Aug.
2021.
| DOI: | 10.3324/haematol.2021.279000 |
T. Aschman,
J. Schneider,
S. Greuel,
J. Meinhardt,
S. Streit and
e. a. Goebel,
"Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died",
JAMA Neurol,
vol. 78,
pp. 948—960,
2021.
T. Aschman,
J. Schneider,
S. Greuel,
J. Meinhardt,
S. Streit,
H. Goebel,
I. Büttnerova,
S. Elezkurtaj,
F. Scheibe,
J. Radke,
C. Meisel,
C. Drosten,
H. Radbruch,
F. Heppner,
V. Corman and
W. Stenzel,
"Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died",
JAMA Neurol,
vol. 78,
no. 8,
pp. 948-960,
Aug.
2021.
| DOI: | 10.1001/jamaneurol.2021.2004 |
T. Aschman,
J. Schneider,
S. Greuel,
J. Meinhardt,
S. Streit,
H. Goebel,
I. Büttnerova,
S. Elezkurtaj,
F. Scheibe,
J. Radke,
C. Meisel,
C. Drosten,
H. Radbruch,
F. L. Heppner,
V. M. Corman and
W. Stenzel,
"Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died",
JAMA Neurology,
vol. 78,
no. 8,
pp. 948—960,
Aug.
2021.
| DOI: | 10.1001/jamaneurol.2021.2004 |
| Datei: | https://doi.org/10.1001/jamaneurol.2021.2004 |
O. Pogarell,
L. Pröbstl,
M. Rüb,
H. Wiegand,
O. Tüscher,
K. Lieb,
E. Wassiliwizky,
G. Gerlinger,
A. Heinz and
P. Falkai,
"Auswirkungen der COVID-19-Pandemie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland",
Der Nervenarzt,
vol. 92,
no. 6,
pp. 562—570,
2021.
| DOI: | 10.1007/s00115-021-01129-6 |
J. Klüpfel,
R. C. Koros,
K. Dehne and
et al,
"Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA)",
Anal Bioanal Chem,
vol. 413,
no. 22,
2021.
| DOI: | 10.1007/s00216-021-03315-6 |
[en]
K. Evert,
T. Dienemann,
C. Brochhausen,
D. Lunz,
M. Lubnow,
M. Ritzka,
F. Keil,
M. Trummer,
A. Scheiter,
B. Salzberger,
U. Reischl,
P. Boor,
A. Gessner,
J. Jantsch,
D. F. Calvisi,
M. Evert,
B. Schmidt and
M. Simon,
"Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation",
Virchows Archiv,
vol. 479,
no. 1,
pp. 97—108,
Jul.
2021.
Abstract:
Between April and June 2020, i.e., during the first wave of pandemic coronavirus disease 2019 (COVID-19), 55 patients underwent long-term treatment in the intensive care unit at the University Hospital of Regensburg. Most of them were transferred from smaller hospitals, often due to the need for an extracorporeal membrane oxygenation system. Autopsy was performed in 8/17 COVID-19-proven patients after long-term treatment (mean: 33.6 days). Autopsy revealed that the typical pathological changes occurring during the early stages of the disease (e.g., thrombosis, endothelitis, capillaritis) are less prevalent at this stage, while severe diffuse alveolar damage and especially coinfection with different fungal species were the most conspicuous finding. In addition, signs of macrophage activation syndrome was detected in 7 of 8 patients. Thus, fungal infections were a leading cause of death in our cohort of severely ill patients and may alter clinical management of patients, particularly in long-term periods of treatment.
| DOI: | 10.1007/s00428-020-03014-0 |
| Datei: | https://doi.org/10.1007/s00428-020-03014-0 |
Abstract:
Between April and June 2020, i.e., during the first wave of pandemic coronavirus disease 2019 (COVID-19), 55 patients underwent long-term treatment in the intensive care unit at the University Hospital of Regensburg. Most of them were transferred from smaller hospitals, often due to the need for an extracorporeal membrane oxygenation system. Autopsy was performed in 8/17 COVID-19-proven patients after long-term treatment (mean: 33.6 days). Autopsy revealed that the typical pathological changes occurring during the early stages of the disease (e.g., thrombosis, endothelitis, capillaritis) are less prevalent at this stage, while severe diffuse alveolar damage and especially coinfection with different fungal species were the most conspicuous finding. In addition, signs of macrophage activation syndrome was detected in 7 of 8 patients. Thus, fungal infections were a leading cause of death in our cohort of severely ill patients and may alter clinical management of patients, particularly in long-term periods of treatment.
K. Evert,
T. Dienemann,
C. Brochhausen,
D. Lunz,
M. Lubnow,
M. Ritzka,
F. Keil,
M. Trummer,
A. Scheiter,
B. Salzberger and
D. Stahl,
"Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation",
Virchows Arch,
pp. 1-12,
2021.
| DOI: | 10.1007/s00428-020-03014-0 |
[en]
J. Ihlow,
E. Michaelis,
S. Greuel,
V. Heynol,
A. Lehmann,
H. Radbruch,
J. Meinhardt,
F. Miller,
H. Herbst,
V. M. Corman,
J. Westermann,
L. Bullinger,
D. Horst,
A. Brünneck and
S. Elezkurtaj,
"B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased",
International Journal of Infectious Diseases,
vol. 103,
pp. 628—635,
Feb.
2021.
| DOI: | 10.1016/j.ijid.2020.12.078 |
| Datei: | https://www.sciencedirect.com/science/article/pii/S1201971220326023 |
P. Arora and
et al,
"B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination",
Cell Reports,
pp. 109825,
2021.
| DOI: | 10.1016/j.celrep.2021.109825 |
C. Bartenschlager,
C. Römmele and
S. Temizel,
"Befragung zum Besuchsmanagement: Wie Pflegeeinrichtungen Besuche während der COVID-19-Pandemie organisierten. Protzenziale digitaler Systeme kaum genutzt",
CAREkonkret,
vol. 32/33,
2021.
| Datei: | https://opus.bibliothek.uni-augsburg.de/opus4/88555 |
S. Kumar,
D. Çalışkan,
J. Janowski,
A. Faist,
B. Conrad and
e. a. Lange,
"Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics",
Front Immunol,
vol. 12,
pp. 752227,
2021.
[de]
S. Traxler,
M. Schindler,
H. Bösmüller and
K. Klingel,
"Biologie und Pathologie von Coronaviren",
Der Pathologe,
vol. 42,
no. 2,
pp. 149—154,
Mä.
2021.
| DOI: | 10.1007/s00292-021-00923-y |
| Datei: | https://doi.org/10.1007/s00292-021-00923-y |
S. Traxler,
M. Schindler,
H. Bösmüller and
K. Klingel,
"Biologie und Pathologie von Coronaviren [Biology and pathology of coronaviruses]",
Pathologe,
vol. 42,
no. 2,
pp. 149-154,
2021.
[en]
J. Swoboda,
D. Wittschieber,
J. Sanft,
S. Kleemann,
S. Elschner,
H. Ihle,
M. Hubig,
M. W. Pletz,
G. Mall and
N. Gaßler,
"Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2",
Histopathology,
vol. 78,
no. 5,
pp. 727—737,
Apr.
2021.
| DOI: | 10.1111/his.14281 |
| Datei: | https://onlinelibrary.wiley.com/doi/abs/10.1111/his.14281 |
J. Swoboda,
D. Wittschieber,
J. Sanft,
S. Kleemann,
S. Elschner,
H. Ihle,
M. Hubig,
M. Pletz,
G. Mall and
N. Gassler,
"Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2",
Histopathology,
vol. 78,
no. 5,
pp. 727-737,
Apr.
2021.
| DOI: | 10.1111/his.14281 |
J. Burns,
A. Movsisyan,
E. Rehfuess and
J. Stratil,
"Border control and SARS-CoV-2: an opportunity for generating highly policy-relevant, real-world evidence",
Journal of Travel Medicine,
pp. 1—3,
2021.
| DOI: | 10.1093/jtm/taab037 |
V. Priesemann,
M. M. Brinkmann,
S. Ciesek,
S. Cuschieri,
T. Czypionka,
G. Giordano,
C. Hanson,
N. Hens,
E. Iftekhar,
P. Klimek,
M. Kretzschmar,
A. Peichl,
M. Perc,
F. Sannino,
E. Schernhammer,
A. Schmidt,
A. Staines and
E. Szczurek,
"Call for a pan-European COVID-19 response must be comprehensive – Authors‘ reply",
The Lancet,
vol. 397,
no. 10284,
pp. 1541,
2021.
| DOI: | 10.1016/S0140-6736(21)00462-1 |
V. Priesemann,
M. M. Brinkmann,
S. Ciesek,
S. Cuschieri,
T. Czypionka,
G. Giordano,
D. Gurdasani,
C. Hanson,
N. Hens,
E. Iftekhar,
M. Kelly-Irving,
P. Klimek,
M. Kretzschmar,
A. Peichl,
M. Perc,
F. Sannino,
E. Schernhammer,
A. Schmidt,
A. Staines and
E. Szczurek,
"Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections",
The Lancet,
vol. 397,
no. 10269,
pp. 92—93,
2021.
| DOI: | 10.1016/S0140-6736(20)32625-8 |
H. Bräuninger,
B. Stoffers,
A. Fitzek and
et al,
"Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart",
Cardiovasc Res,
pp. cvab322,
2021.
| DOI: | 10.1093/cvr/cvab322 |
[en]
S. Elezkurtaj,
S. Greuel,
J. Ihlow,
E. G. Michaelis,
P. Bischoff,
C. A. Kunze,
B. V. Sinn,
M. Gerhold,
K. Hauptmann,
B. Ingold-Heppner,
F. Miller,
H. Herbst,
V. M. Corman,
H. Martin,
H. Radbruch,
F. L. Heppner and
D. Horst,
"Causes of death and comorbidities in hospitalized patients with COVID-19",
Scientific Reports,
vol. 11,
no. 1,
pp. 4263,
Feb.
2021.
| DOI: | 10.1038/s41598-021-82862-5 |
| Datei: | https://www.nature.com/articles/s41598-021-82862-5 |
J. Doehn,
C. Tabeling,
R. Biesen,
J. Saccomanno,
E. Madlung,
E. Pappe,
F. Gabriel,
F. Kurth,
C. Meisel,
V. Corman and
D. Stahl,
"CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity",
Infection,
vol. 49,
no. 4,
pp. 757—762,
2021.
| DOI: | 10.1007/s15010-021-01606-9 |
J. Doehn,
C. Tabeling,
R. Biesen,
J. Saccomanno,
E. Madlung,
E. Pappe,
F. Gabriel,
F. Kurth,
C. Meisel,
V. Corman,
L. Hanitsch,
S. Treskatsch,
K. Heim,
M. S. Stegemann,
C. Ruwwe-Glösenkamp,
H. C. Müller-Redetzky,
A. Uhrig,
R. Somasundaram,
C. Spies,
H. Bernuth,
J. Hofmann,
C. Drosten,
N. Suttorp,
M. Witzenrath,
L. E. Sander and
R. Hübner,
"CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.",
Infection.2021;49(4):757-762,
2021.
B. Lorenz-Depiereux,
J. J. Vehreschild,
M. Stecher,
L. Pilgram,
M. Witzenrath,
C. Pley,
C. Thibeault,
S. Schreiber,
T. Bahmer,
L. Fiedler-Lacombe,
A. Blumentritt,
M. Stahl,
W. Hoffmann,
S. Hanß,
D. Krefting,
C. Schäfer,
M. Nauck,
J. Schaller,
M. Hoffmann,
M. Kraus and
On Behalf Of The Napkon Study Group,
"Challenges for Ethics coordination in a large Cohort Network – experiences in the German National Pandemic Cohort Network NAPKON.",
Kongress European Biobank Week 2021,
2021.
A. Walker,
T. Houwaart,
P. Finzer and
et al,
"Characterization of SARS-CoV-2 genetic structure and infection clusters in a large German city based on integrated genomic surveillance, outbreak analysis, and contact tracing",
Epidemiology,
2021.
| DOI: | 10.1101/2021.02.13.21251678 |
| Datei: | https://doi.org/10.1101/2021.02.13.21251678 |
A. Walker,
T. Houwaart,
P. Finzer and
et al,
"Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting",
Clin Infect Dis,
vol. 74,
no. 6,
2021.
| DOI: | 10.1093/cid/ciab588 |
A. Walker,
T. Houwaart,
P. Finzer,
L. Ehlkes,
A. Tyshaieva,
M. Damagnez,
D. Strelow,
A. Duplessis,
J. Nicolai,
T. Wienemann,
T. Tamayo,
M. K. Vasconcelos,
L. Huelse,
K. Hoffmann,
N. Luebke,
S. Hauka,
M. Andree,
M. P. Daeumer,
A. Thielen,
S. Kolbe-Busch,
K. Goebels,
R. Zotz,
K. Pfeffer,
J. Timm,
A. T. Dilthey and
G. C. O. I. (DeCOI),
"Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting",
Clinical Infectious Diseases,
2021.
| DOI: | 10.1093/cid/ciab588 |
| Datei: | https://doi.org/10.1093/cid/ciab588 |
A. Walker,
T. Houwaart,
P. Finzer,
L. Ehlkes,
A. Tyshaieva,
M. Damagnez,
D. Strelow,
A. Duplessis,
J. Nicolai,
T. Wienemann,
T. Tamayo,
M. Kohns Vasconcelos,
L. Hülse,
K. Hoffmann,
N. Lübke,
S. Hauka,
M. Andree,
M. Däumer,
A. Thielen,
S. Kolbe-Busch,
K. Göbels,
R. Zotz,
K. Pfeffer,
J. Timm,
A. Dilthey and
German COVID-19 OMICS Initiative (DeCOI),
"Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting",
Clin Infect Dis,
no. 6,
pp. 1039-1046,
Mä.
2021.
| DOI: | 10.1093/cid/ciab588 |
A. Walker,
T. Houwaart,
P. Finzer,
L. Ehlkes,
A. Tyshaieva,
M. Damagnez,
D. Strelow,
A. Duplessis,
J. Nicolai,
T. Wienemann,
T. Tamayo,
M. Kohns Vasconcelos,
L. Hülse,
K. Hoffmann,
N. Lübke,
S. Hauka,
M. Andree,
M. Däumer,
A. Thielen,
S. Kolbe-Busch,
K. Göbels,
R. Zotz,
K. Pfeffer,
J. Timm,
A. Dilthey and
German COVID-19 OMICS Initiative (DeCOI),
"Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting",
Clin Infect Dis,
no. 6,
pp. 1039-1046,
Mä.
2021.
| DOI: | 10.1093/cid/ciab588 |
J. Ankerhold,
S. Giese,
P. Kolb and
et al,
"Circulating multimeric immune complexes drive immunopathology in COVID-19",
Immunology,
2021.
| DOI: | 10.1101/2021.06.25.449893 |
[en]
P. Hofman,
M. Ilié,
E. Chamorey,
P. Brest,
R. Schiappa,
V. Nakache,
M. Antoine,
M. Barberis,
H. Begueret,
F. Bibeau,
C. Bonnetaud,
P. Boström,
P. Brousset,
L. Bubendorf,
L. Carvalho,
G. Cathomas,
A. Cazes,
L. Chalabreysse,
M. -. Chenard,
M. -. Copin,
J. -. Côté,
D. Damotte,
L. Leval,
P. Delongova,
V. Montpreville,
A. Muret,
A. Dema,
W. Dietmaier,
M. Evert,
A. Fabre,
F. Forest,
A. Foulet,
S. Garcia,
M. Garcia-Martos,
L. Gibault,
G. Gorkiewicz,
D. Jonigk,
J. Gosney,
A. Hofman,
I. Kern,
K. Kerr,
M. Kossai,
M. Kriegsmann,
S. Lassalle,
E. Long-Mira,
A. Lupo,
A. Mamilos,
R. Matěj,
J. Meilleroux,
C. Ortiz-Villalón,
L. Panico,
A. Panizo,
M. Papotti,
P. Pauwels,
G. Pelosi,
F. Penault-Llorca,
O. Pop,
N. Poté,
S. R. Y. Cajal,
J. -. Sabourin,
I. Salmon,
M. Sajin,
S. Savic-Prince,
H. -. Schildhaus,
P. Schirmacher,
I. Serre,
E. Shaw,
D. Sizaret,
A. Stenzinger,
J. Stojsic,
E. Thunnissen,
W. Timens,
G. Troncone,
C. Werlein,
H. Wolff,
J. -. Berthet,
J. Benzaquen,
C. -. Marquette,
V. Hofman and
F. Calabrese,
"Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future",
ESMO Open,
vol. 6,
no. 1,
pp. 100024,
Feb.
2021.
| DOI: | 10.1016/j.esmoop.2020.100024 |
| Datei: | https://www.sciencedirect.com/science/article/pii/S2059702920328891 |
C. Thibeault,
B. Mühlemann,
E. Helbig,
M. Mittermaier,
T. Lingscheid,
P. Tober-Lau,
L. Meyer-Arndt,
L. Meiners,
P. Stubbemann,
S. Haenel and
D. Stahl,
"Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study",
Infection,
vol. 49,
no. 4,
pp. 703—714,
2021.
| DOI: | 10.1007/s15010-021-01594-w |
C. Thibeault and
et al,
"Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study",
Infection,
2021.
| DOI: | 10.1007/s15010-021-01594-w |
D. Nörz,
A. Hoffmann,
M. Aepfelbacher,
S. Pfefferle and
M. Lütgehetmann,
"Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform",
Journal of Medical Microbiology,
vol. 70,
no. 2,
pp. 001295,
Feb.
2021.
| DOI: | 10.1099/jmm.0.001295 |
| Datei: | https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.001295 |
[eng]
Y. Zhao,
C. Kilian,
J. Turner,
L. Bosurgi,
K. Roedl,
P. Bartsch,
A. Gnirck,
F. Cortesi,
C. Schultheiß,
M. Hellmig,
L. U. B. Enk,
F. Hausmann,
A. Borchers,
M. N. Wong,
H. Paust,
F. Siracusa,
N. Scheibel,
M. Herrmann,
E. Rosati,
P. Bacher,
D. Kylies,
D. Jarczak,
M. Lütgehetmann,
S. Pfefferle,
S. Steurer,
J. S. Zur-Wiesch,
V. G. Puelles,
J. Sperhake,
M. M. Addo,
A. W. Lohse,
M. Binder,
S. Huber,
T. B. Huber,
S. Kluge,
S. Bonn,
U. Panzer,
N. Gagliani and
C. F. Krebs,
"Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients",
Science Immunology,
vol. 6,
no. 56,
pp. eabf6692,
Feb.
2021.
| DOI: | 10.1126/sciimmunol.abf6692 |
A. Mikolajewska,
A. Fischer,
V. Piechotta,
A. Mueller,
M. Metzendorf,
M. Becker,
E. Dorando,
R. Pacheco,
A. L. C. Martimbianco,
R. Riera,
N. Skoetz and
M. Stegemann,
"Colchicine for the treatment of COVID‐19",
Cochrane Database of Systematic Reviews,
vol. 2021,
pp. CD015045,
2021.
| DOI: | 10.1002/14651858.CD015045 |
M. Ochs,
S. Timm,
S. Elezkurtaj,
D. Horst,
J. Meinhardt and
e. a. Heppner,
"Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient",
Eur Respir J,
vol. 57,
2021.
| DOI: | 10.1183/13993003.02311-2020 |
K. Herbst,
M. Meurer,
D. Kirrmaier and
D. Stahl,
"Colorimetric RT-LAMP and LAMP-sequencing for Detecting SARS-CoV-2 RNA in Clinical Samples",
BIO-Protocols,
vol. 11,
no. 6,
2021.
| DOI: | 10.21769/BioProtoc.3964 |
| Datei: | https://doi.org/10.21769/BioProtoc.3964 |
L. Brunotte,
S. Zheng,
A. Mecate-Zambrano,
J. Tang,
S. Ludwig and
e. a. Rescher,
"Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro",
Pharmaceutics,
vol. 13,
2021.
A. Müller,
F. Engler,
D. Schütze,
P. Nohl-Deryk and
C. Güthlin,
"Communication experience by secure instant messaging during the Covid-19 pandemic for general practitioners and public health workers – a qualitative analysis",
Doc21dkvf051,
2021.
| DOI: | 10.3205/21dkvf051 |
A. Osterman,
M. Iglhaut,
A. Lehner,
P. Spaeth,
M. Stern,
H. Autenrieth,
M. Muenchhoff,
A. Graf,
S. Krebs,
H. Blum,
A. Baiker,
N. Grzimek-Koschewa,
U. Protzer,
L. Kaderali,
H. Baldauf and
O. T. Keppler,
"Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern",
Medical Microbiology and Immunology,
2021.
| DOI: | 10.1007/s00430-021-00719-0 |
| Datei: | https://doi.org/10.1007/s00430-021-00719-0 |
A. Osterman,
M. Iglhaut,
A. Lehner,
P. Späth,
M. Stern,
H. Autenrieth,
M. Muenchhoff,
A. Graf,
S. Krebs,
H. Blum,
A. Baiker,
N. Grzimek-Koschewa,
U. Protzer,
L. Kaderali,
H. Baldauf and
O. Keppler,
"Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern",
Med Microbiol Immunol,
no. 210,
pp. 263-275,
Dez.
2021.
| DOI: | 10.1007/s00430-021-00719-0 |
A. Osterman,
M. Iglhaut,
A. Lehner and
et al,
"Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern",
Med Microbiol Immunol,
vol. 210,
2021.
| DOI: | 10.1007/s00430-021-00719-0 |
A. Osterman,
M. Iglhaut,
A. Lehner,
P. Späth,
M. Stern,
H. Autenrieth,
M. Muenchhoff,
A. Graf,
S. Krebs,
H. Blum,
A. Baiker,
N. Grzimek-Koschewa,
U. Protzer,
L. Kaderali,
H. Baldauf and
O. Keppler,
"Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern",
Medical microbiology and immunology,
vol. 210,
no. 5-6,
pp. 263—275,
2021.
| DOI: | 10.1007/s00430-021-00719-0 |